Enanta Pharmaceuticals
ENTA
#8176
Rank
ยฃ0.26 B
Marketcap
ยฃ9.14
Share price
-2.18%
Change (1 day)
7.57%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -ยฃ37.62 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.25 Million. In 2025 the company made an earning of -ยฃ48.29 Million, an increase over its 2024 earnings that were of -ยฃ73.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ37.62 Million-22.1%
2025 -ยฃ48.29 Million-34.07%
2024 -ยฃ73.25 Million-23.87%
2023 -ยฃ96.21 Million4.39%
2022 -ยฃ92.17 Million-4.4%
2021 -ยฃ96.41 Million91.12%
2020 -ยฃ50.45 Million-407.13%
2019 ยฃ16.42 M-78.63%
2018 ยฃ76.86 M117.97%
2017 ยฃ35.26 M-574.65%
2016 -ยฃ7.43 Million-110.83%
2015 ยฃ68.62 M-4.5%
2014 ยฃ71.85 M-638.53%
2013 -ยฃ13.35 Million-137.98%
2012 ยฃ35.12 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.78 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.71 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ6.56 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.80 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.80 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.99 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA